Austin Mark John
SEC CIK 1713059 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | VP Fin, Prin Fin, Acct Offic | 84.0K | $5,452 | — | 2 | 2022-06-08 | 2024-04-23 |
Most active insiders at CATX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lantheus Alpha Therapy, LLC | 10% | — | $1.27M |
| 2 | Lantheus Holdings, Inc. | 10% | — | $357.2K |
| 3 | Hunt Jonathan Robert | CAO | $22.3K | — |
| 4 | Williamson Robert F III | Dir | $19.9K | — |
Austin Mark John made no open-market trades at CATX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-24 | 2024-04-23 | CATX | Perspective Therapeutics, Inc. | Austin Mark John | VP Fin, Prin Fin, Acct Offic | M - OptEx | $0.36 | +30.0K | 84.0K | +56% | +$10.8K |
| M | 2022-06-09 | 2022-06-08+ | CATX | Perspective Therapeutics, Inc. | Austin Mark John | VP Fin, Prin Fin, Acct Offic | P - Purchase | $0.29 | +18.8K | 54.0K | +53% | +$5,452 |
Purchase Sale Sale after option exercise All abbreviations